Xtx Topco LTD Neuronetics, Inc. Transaction History

Xtx Topco LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$2.68 - $4.8 $92,824 - $166,252	-34,636 Reduced 74.51%	11,846 $56,000
Q4 2023 Feb 13, 2024	SELL	$1.05 - $2.9 $38,846 - $107,291	-36,997 Reduced 44.32%	46,482 $134,000
Q3 2023 Nov 13, 2023	SELL	$1.29 - $2.22 $37,265 - $64,131	-28,888 Reduced 25.71%	83,479 $112,000
Q2 2023 Aug 14, 2023	SELL	$2.07 - $2.92 $69,208 - $97,627	-33,434 Reduced 22.93%	112,367 $241,000
Q1 2023 May 12, 2023	BUY	$2.81 - $6.71 $284,043 - $678,266	101,083 Added 226.05%	145,801 $424,000
Q4 2022 Feb 14, 2023	BUY	$2.74 - $6.87 $122,527 - $307,212	44,718 New	44,718 $307,000
Q4 2021 Feb 11, 2022	SELL	$3.87 - $6.59 $64,690 - $110,158	-16,716 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$6.22 - $15.54 $103,973 - $259,766	16,716 New	16,716 $110,000

18.3M

3.8K

Ticker STIM
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 27,022,800
Market Cap $20.5M
Description
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

Stay updated on Xtx Topco LTD with notifications on news.